Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
THERAPEUTIC AGENT FOR FIBROSIS
Document Type and Number:
WIPO Patent Application WO/2019/022257
Kind Code:
A1
Abstract:
Disclosed is a phosphorylation inhibitor for SMAD2/3 proteins or a therapeutic agent for fibrosis which comprises, as an active ingredient, a nucleic acid suppressing the expression of NEK6 (NIMA-related serine/threonine kinase 6) gene.

Inventors:
NAKAO KAZUHISA (JP)
ISHIYAMA JUNICHI (JP)
ICHIKAWA WATARU (JP)
MASUI ATSUSHI (JP)
AKASAKA YUNIKE (JP)
TOYOFUKU HIDEKAZU (JP)
HONDA AYA (JP)
Application Number:
PCT/JP2018/028459
Publication Date:
January 31, 2019
Filing Date:
July 30, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
KYORIN SEIYAKU KK (JP)
International Classes:
A61K31/713; A61K31/7088; A61K31/7105; A61K47/54; A61K48/00; A61P11/00; A61P43/00; C12N15/113
Domestic Patent References:
WO2012017919A12012-02-09
WO2012017919A12012-02-09
WO2012005368A12012-01-12
WO2012017919A12012-02-09
WO2013027843A12013-02-28
WO2016159374A12016-10-06
WO2013027843A12013-02-28
Foreign References:
US20040097441A12004-05-20
US20040097441A12004-05-20
US3687808A1972-08-29
Other References:
LIMBACH ET AL.: "Summary: the modified nucleosides of RNA", NUCLEIC ACIDS RES., vol. 22, 1994, pages 2183 - 2196, XP001152667
"Concise Encyclopedia Of Polymer Science And Engineering", 1990, JOHN WILEY & SONS, pages: 858 - 859
ENGLISCH ET AL.: "Angewandte Chemie", vol. 30, 1991, pages: 613
See also references of EP 3659609A4
Attorney, Agent or Firm:
HASEGAWA Yoshiki et al. (JP)
Download PDF: